CD19 and systemic lupus erythematosus: Our results demonstrate that Hu19-CD828z CAR T-cells exhibit CAR-mediated, CD19-dependent activity against autologous B-cells, with comparably low inflammatory cytokine production when derived from cells from SLE, IIM, and SSc patients and healthy donors.